Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain, Postoperative 2Neoplasms 2Agnosia 2Pain 1Lung Neoplasms 1Leiomyoma 1Feeding and Eating Disorders 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Ropivacaine × Clear all
NCT00210132 2025-09-08

ROPAL-1

Institut Bergonié

Phase 2 Completed
90 enrolled 6 charts

Neoplasms, Pain, Postoperative

NCT04250805 2024-01-31

GASTROXY

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Terminated
17 enrolled

Feeding and Eating Disorders, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡